Efficacy and safety of glatiramer acetate in multiple sclerosis patients with allergic respiratory diseases

被引：0
作者：
Mallucci, G.
La Mantia, L.
Confalonieri, P. A.
Galgani, S.
Haggiag, S.
Lugaresi, A.
De Luca, G.
Solaro, C.
Trabucco, E.
Meola, G.
Robotti, M.
Cavaletti, G.
Frigeni, B.
Clerici, R.
Chiveri, L.
Bono, G.
Banfi, P.
Ambrosoni, E.
Mancardi, L.
Della Cava, F.
Balgera, R.
Bergamaschi, R.
机构：
[1] Fdn Ist Neurol Nazl C Mondino IRCCS, Pavia, Italy
[2] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[3] Azienda Osped San Camillo Forlanini, Rome, Italy
[4] Policlin SS Annunziata, Chieti, Italy
[5] ASL3 Genovese, Genoa, Italy
[6] IRCCS Policlin San Donato, Milan, Italy
[7] Azienda Osped San Gerardo, Monza, Italy
[8] Osped Valduce, Como, Italy
[9] Osped Circolo Varese, Varese, Italy
[10] Fdn Macchi, Varese, Italy
[11] IRCCS Azienda Osped Univ San Martino, Genoa, Italy
[12] Azienda Osped Prov Lecco, Lecce, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：428 / 429
页数：2
相关论文
共 50 条
  • [11] Glatiramer acetate for relapsing multiple sclerosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1997, 39 (1004): : 61 - 62
  • [12] Glatiramer acetate for the treatment of multiple sclerosis
    Wolinsky, JS
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (04) : 875 - 891
  • [13] Glatiramer Acetate (Copaxone®) in the Treatment of Relapsing/Remitting Cerebrospinal Multiple Sclerosis - Clinical Efficacy and Safety Profile
    Stourac, P.
    Praksova, P.
    Kontrova, I.
    Hladikova, M.
    Okacova, I.
    Benesova, Y.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2011, 74 (04) : 447 - 454
  • [14] IgE-Mediated Allergic Reactions after the First Administration of Glatiramer Acetate in Patients with Multiple Sclerosis
    Corominas, Mercs
    Postigo, Idoia
    Cardona, Victoria
    Lleonart, Ramon
    Romero-Pinel, Luca
    Martinez, Jorge
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2014, 165 (04) : 244 - 246
  • [15] Glatiramer acetate in the treatment of multiple sclerosis
    Miller, AE
    NEUROLOGIC CLINICS, 2005, 23 (01) : 215 - +
  • [16] Spasticity in multiple sclerosis: a pilot study to evaluate the efficacy of glatiramer acetate
    Meca-Lallana, Jose
    MULTIPLE SCLEROSIS, 2008, 14 : S165 - S165
  • [17] Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate
    Windhagen, A
    Maniak, S
    Marckmann, S
    Wilkening, A
    Lindert, RB
    Heidenreich, F
    Blasczyk, R
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (03) : 415 - 416
  • [18] Persistence and adherence to interferon and glatiramer acetate in patients with multiple sclerosis
    Bartolome-Garcia, Emma
    Usarralde-Perez, Angela
    Sanmartin-Fenollera, Patricia
    Perez-Encinas, Monserrat
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2019, 26 (01) : 23 - 28
  • [19] Metabolic response to glatiramer acetate therapy in multiple sclerosis patients
    De Riccardis, Lidia
    Ferramosca, Alessandra
    Danieli, Antonio
    Trianni, Giorgio
    Zara, Vincenzo
    De Robertis, Francesca
    Maffia, Michele
    BBA CLINICAL, 2016, 6 : 131 - 137
  • [20] Effect of glatiramer acetate on diffusion imaging in patients with multiple sclerosis
    Zivadinov, R.
    Hussein, S.
    Abdelrahman, N.
    Cookfair, D. L.
    Meyer, M.
    Garg, A.
    Cox, J. L.
    Dwyer, M. G.
    Weinstock-Guttman, B.
    MULTIPLE SCLEROSIS, 2006, 12 : S99 - S99
12345